Early Access

10-QPeriod: Q3 FY2009

CORNING INC /NY Quarterly Report for Q3 Ended Sep 30, 2009

Filed November 2, 2009For Securities:GLW

Summary

Corning Incorporated (GLW) reported its third quarter and nine-month results for 2009, showcasing resilience amidst a challenging economic environment. While net sales saw a year-over-year decrease, the company demonstrated effective cost management and strategic investments. Net income for the third quarter was $643 million, or $0.41 per diluted share, compared to $768 million, or $0.49 per diluted share, in the prior year. For the nine-month period, net income was $1.268 billion, or $0.81 per diluted share, a significant decrease from $5.008 billion, or $3.15 per diluted share, in 2008, largely due to the absence of significant one-time tax benefits realized in the prior year. The company also made strategic acquisitions, such as Axygen Bioscience, to strengthen its Life Sciences segment and maintained a strong balance sheet with ample liquidity. The company faced headwinds including price declines in its key Display Technologies segment and disruptions from an earthquake in Japan. However, it benefited from favorable foreign exchange movements and government incentives in certain segments. Corning continues to prioritize financial health and strategic investments in future growth areas, managing capital expenditures and operating costs proactively. The company maintained a strong liquidity position with significant cash reserves and an available credit facility.

Key Highlights

  • 1Net sales for the third quarter decreased by 5% to $1.479 billion, while for the nine-month period, sales declined 21% to $3.863 billion, reflecting impacts of global economic conditions and price declines in key segments.
  • 2Net income attributable to Corning for Q3 2009 was $643 million ($0.41/share), down from $768 million ($0.49/share) in Q3 2008. Year-to-date net income was $1.268 billion ($0.81/share), down significantly from $5.008 billion ($3.15/share) in the prior year, largely due to the absence of significant prior-year tax benefits.
  • 3The company acquired Axygen Bioscience, Inc. for $410 million to bolster its Life Sciences segment, demonstrating a commitment to strategic growth.
  • 4Corning maintained a strong balance sheet with $2.9 billion in cash, cash equivalents, and short-term investments, and a low debt-to-capital ratio of 12%.
  • 5The Display Technologies segment, while facing price declines and an earthquake-related disruption in Japan, showed sequential volume improvements and benefited from favorable foreign exchange rates.
  • 6Restructuring charges of $175 million were recorded year-to-date, primarily related to workforce reductions aimed at reducing costs and aligning operations with anticipated lower sales.
  • 7Equity in earnings of affiliated companies remained significant, contributing $418 million in Q3 and $974 million year-to-date, with key contributions from Samsung Corning Precision and Dow Corning.

Frequently Asked Questions